Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sad1 and UNC84 domain containing 1 (SUN1) is a structural protein localized to the inner nuclear membrane, where it is a core component of the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex[1][2][3][7]. SUN1 physically connects the nuclear lamina to the cytoskeleton, mediating nuclear positioning, movement, and the transmission of mechanical forces across the nuclear envelope[1][2][3]. It is essential for interkinetic nuclear migration in neuronal progenitors, the maturation of focal adhesions, actin cytoskeleton organization, and telomere attachment during meiosis[1][2]. Mutations in SUN1 have been associated with Emery-Dreifuss muscular dystrophy and rare developmental disorders, including neurological and muscular symptoms[1][2][4][5]. SUN1 is not a typical direct therapeutic target such as a receptor or enzyme, but its dysfunction is linked to various tissue pathologies due to deficits in nuclear-cytoskeletal communication[2][1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sad1 and UNC84 domain containing 1 (SUN1).